MedPath

Diabetes Nutrition Algorithms - Sugars: Galactose- and Fiber-induced Metabolic Improvement in the Dietetic Treatment of Type 2 Diabetes

Not Applicable
Conditions
Type 2 Diabetes
Interventions
Dietary Supplement: Dietary supplement (4 arms, 2 active, 2 placebo)
Registration Number
NCT01776099
Lead Sponsor
German Institute of Human Nutrition
Brief Summary

In animal models and retrospective studies, certain food components such as sugars and fiber have been detected as potential agents to influence development and progress of type 2 diabetes.

The DiNA study prospectively investigates, if non-soluble non-fermentable fibers (vs. soluble ones) and galactose (vs. palatinose) are capable to improvement metabolic parameters in patients with long-term type 2 diabetes and intensive insulin treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • type 2 diabetes, insulin-dependent
  • high insulin resistance
Exclusion Criteria
  • accompanying disease, medication or metabolic disorder, which interact with glucose metabolism or eating behavior (e.g. renal insufficiency, major cardial insuffiency, untreated hypothyreosis, corticoid treatment, depression and other psychiatric disorders...)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
soluble non-fermentable fibersDietary supplement (4 arms, 2 active, 2 placebo)5 grams of soluble non-fermentable fibers, three times a day with the main meals, duration: 4 weeks
pure galactoseDietary supplement (4 arms, 2 active, 2 placebo)5 grams of galactose, three times a day with the main meals, duration: 4 weeks
pure palatinoseDietary supplement (4 arms, 2 active, 2 placebo)5 grams of palatinose, three times a day with the main meals, duration: 4 weeks
non-soluble non-fermentable fibersDietary supplement (4 arms, 2 active, 2 placebo)5 grams of non-soluble non-fermentable fibers, three times a day with each main meal, duration: 4 weeks
Primary Outcome Measures
NameTimeMethod
metabolic improvement of type 2 diabetes4 weeks

metabolic improvement of type 2 diabetes, as to be shown via hyperinsulinemic-euglycaemic clamp, mixed-meal test and daily demand of insulin units

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Charité-Klinikum Benjamin Franklin

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath